RCM
HALO icon

Reynolds Capital Management’s Halozyme HALO Stock Holding History

Reynolds Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,100
Closed -$228K – 161
2015
Q2 		$228K Buy
+10,100
New +$178K 0.22% 169

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Reynolds Capital Management's HALO Position: Q3 2015 in Review

Reynolds Capital Management sold out of Halozyme (HALO) in Q3 2015, closing a stake of 10,100 shares — an estimated $228K sold.

Reynolds Capital Management first reported a position in HALO in Q2 2015 and held it in 1 quarter. The position peaked at $228K in Q2 2015. 175 funds tracked by Wall St. Rank hold HALO as of Q3 2015.

  • Reynolds Capital Management reported no remaining Halozyme position as of Q3 2015 after selling out during the quarter.
  • Reynolds Capital Management sold 10,100 Halozyme shares in Q3 2015, an estimated $228K.
  • Reynolds Capital Management first reported a position in Halozyme in Q2 2015 and held it in 1 quarter.
  • Reynolds Capital Management's Halozyme position peaked at $228K in Q2 2015.
  • 175 funds tracked by Wall St. Rank held Halozyme as of Q3 2015.

Based on Reynolds Capital Management's 13F filing for Q3 2015, filed 22 Oct 2015.